Collection of human genomic DNA from neonates: a comparison between umbilical cord blood and buccal swabs




Objective


To compare DNA yield from neonatal umbilical cord blood and buccal swab specimens.


Study Design


Umbilical cord blood was obtained at birth in a cohort of women enrolled in a preterm labor study. If cord blood was not obtained, neonatal buccal samples were obtained using the Oragene saliva kits. DNA was extracted from all samples using the QIAamp extraction kits. DNA concentration and yield were compared between umbilical cord blood and buccal swabs.


Results


DNA concentrations from umbilical cord blood (n = 35) was greater than that obtained from buccal swabs (n = 20) (total sample: 209.0 ± 110.7 ng/μL vs 6.9 ± 6.7 ng/μL respectively, P < .001; partial sample: n = 30 cord blood vs n = 11 buccal, 70.0 ± 51.4 ng/μL vs 11.3 ± 6.7 ng/μL, respectively, P < .001) and produced more total DNA (total sample: 116.5 ± 70.8 μg vs 4.2 ± 4.0 μg, P < .001; partial:14.0 ± 10.3 μg vs 1.1 ± 0.7 μg, respectively, P < .001).


Conclusion


Buccal swabs yield less neonatal DNA than umbilical cord blood specimens.


Obtaining and storing neonatal genetic samples is an emerging research need. The use of biorepositories has become a critical resource for large scale epidemiologic studies, candidate gene and genome-wide association studies (GWAS), and molecular-based biomedical research, bridging the gap between molecular and clinical information. Critical to this endeavor is the ability to easily, conveniently, and cost-effectively acquire high yields of quality DNA from participants.


Advances in high-throughput genotyping technologies now allow us to assay for thousands of genotypes quickly and with relatively small amounts of DNA (∼1-5 ng DNA per assay). However, the samples collected for biorepositories are carefully characterized populations whose finite amount of DNA collected must be maximized to attain increased information, including providing for evaluation of future biomarkers to minimize research costs. Collection of umbilical cord blood is ideal for obtaining DNA from neonates, but the unpredictable nature of birth makes obtaining these samples difficult at times. Although saliva is a robust source of DNA from adults when blood is not available, studies are lacking about the robustness of sample alternatives to umbilical cord blood for the neonate. Review of the literature revealed no studies or data comparing neonatal salivary sample DNA yield to that from umbilical cord blood.


The objective of this study was to compare the DNA yield from neonatal specimens obtained at or just after birth. The hypothesis is that the yield of DNA from neonatal salivary swabs would be equivalent to that from umbilical cord blood and thus would be adequate for genetic studies and biorepositories.


Materials and Methods


Study population


Our study population consisted of neonates of pregnant women who had been admitted to the hospital with a diagnosis of threatened preterm birth who had received at least 1 dose of antenatal corticosteroids. The women, admitted to 1 of 2 urban hospitals, were recruited to a study and gave consent for obtaining samples for DNA from their newborn infants. Women who consented were at least 23 weeks’ gestation and ≥18 years old.


Sample collection and processing


Blood samples. Umbilical cord blood samples were obtained immediately after delivery in K 2 EDTA vacutainers by trained cord blood collectors. Samples were mixed by inversion 8-10 times after being drawn and then stored at −80 °C until DNA isolation.


Saliva samples. If umbilical cord blood was not acquired at the time of delivery because of an offhour delivery when the study personnel were not available, a trained member of the research team obtained buccal swabs from the neonate. For buccal cell collection, we used Oragene saliva kit collection with cotton swabs. Oragene kits are shown to reduce microbial contamination and provide immediate stabilization of samples, allowing it to be stored at room temperature for years without processing or DNA degradation. Oragene “Saliva collection with cotton swabs or buccal brushes” protocol was followed. Collection protocols call for collector to grip swab without contaminating cotton tip and gently place the cotton tips inside of the infant’s mouth, collecting as much saliva as possible by rubbing the cheeks and moving the tip into the spaces between the check and gums and under the tongue. Once saturated in saliva, tips were cut off of swabs into the base of the Oragene collection vial. This process was repeated until the 5 cotton tips that come with the collection kit were inside of the collection vial. Immediately on collection, the Oragene vial cap, which contains the Oragene · DNA solution was placed onto the base and tightened securely. The vial was shaken vigorously and inverted to ensure that the cotton tips were well mixed with the Oragene · DNA preservation fluid. Kits were then stored at room temperature. Before purification, the Oragene saliva sample kits were briefly mixed by gentle inversion and incubated for a minimum of 2 hours in an air incubator set to 50°C. To remove saliva from buccal swabs, manufacturer protocols for “DNA Recovery from Saliva Sponges” were followed. First, free liquid was removed and transferred into a 15-mL conical centrifuge tube. A barrel of a 5-mL disposable plastic syringe (with the plunger removed) was placed into the same tube. Sterile, disposable forceps were used to transfer the sponges from the kit collection base into the barrel of the syringe. The syringe barrel containing the sponges in the tube was centrifuged at 200× g for 10 minutes at 20°C. The barrel containing the dry sponges was discarded and the tube containing the recovered liquid was capped, labeled, and stored at room temperature until purification.


DNA isolation


DNA was extracted from umbilical cord blood samples using the QIAamp DNA mini, midi, or maxi kits (Qiagen Inc, Valencia, CA). The specific kit used was chosen based on sample volume collected and period of collection. As with the buccal swab samples, we originally extracted only a portion of the sample collected but later began extracting the full sample to attain maximal DNA yield. Kits are designed to extract the following sample volumes: mini (0.2 mL), midi (1-2 mL), and maxi (3-5 mL). Initially, all samples were extracted using the minikit. Subsequent samples were extracted using the kit whose volume capacity best fit the total sample volume collected. Manufacturer spin protocol instructions were followed for all kits with one modification. Our equipment was not capable of reaching 4500× g for large tube sizes. For steps where the manufacturer protocol called for centrifugation at 4500× g , we used 3100× g and compensated this difference by using increased spin times. When manufacturer’s protocols listed steps for highly concentrated DNA, those steps were followed. Isolated DNA was transferred into cyrovials and all samples were stored at −80°C until quantification.


DNA was purified from saliva swab samples using the Oragene Kit (DNA Genotek) manufacturer recommendations. Two procedures were used throughout the course of the study. Initially, 500 μL of sample was transferred to a 1.5-mL Eppendorf tube and purified. However, we found DNA yield insufficient using only a portion of the collected sample prompting us to extract the entire sample volume collected from subsequent participant samples. Oragene saliva kits are designed to collect 2 mL saliva, which are then added together with 2 mL Oragene · DNA present in the cap of each kit resulting in 4 mL total sample to be extracted. However, using the “saliva collection with cotton swabs or buccal brushes” and “DNA recovery from saliva sponges” protocols, only minimal volumes of saliva were recovered (≤200 μL). Regardless of sample volume that used DNA isolation was performed according to manufacturer’s instructions. Samples were frozen at −80°C until quantification.


DNA quantification


Concentration of double-stranded DNA in our samples was determined using a Quant-iT double-stranded DNA (dsDNA) broad range or high-sensitivity assay kit and Qubit Flouromter (Invitrogen, Carlsbad, CA). This system uses a fluorescent nucleic acid stain to accurately and specifically measure dsDNA at highly sensitive levels.


DNA quality assessment by gel electrophoresis


The DNA quality was assessed by analyzing the samples for evidence of degradation using gel electrophoresis. Samples of both buccal and umbilical cord blood genomic DNA (180 ng each sample) were run on an agarose gel (0.9% agarose) and stained with ethidium bromide. The size of the DNA was determined by comparison with a DNA ladder (1 kb; Life Technologies). The largest band in the ladder is approximately 10 kb. High-quality DNA is expected to be mostly >10 kb.


Statistical analysis


All results were analyzed with SPSS, version 17.0 (SPSS, Inc, Chicago, IL). Nonparametric tests were used to compare mean total yield and concentration of DNA collected from Oragene buccal swab collection samples and umbilical cord blood samples because the samples were not normally distributed. We used the Mann-Whitney U test. We also compared the DNA concentration between extraction protocols for partial sample extraction and complete sample extraction. For the purposes of comparison umbilical cord blood and buccal swab samples were each separated into 2 groups based on whether the entire blood or buccal cell sample collected or a portion of the entire sample collected was isolated in this study. In addition, a linear regression analysis was performed to compare the possible effect of gestational age at cord blood collection and day of life at buccal swab collection on DNA yield measures.




Results


Ninety-six patient samples were included in this analysis. We were able to collect 65 umbilical cord blood samples (68%) at the time of delivery and collected neonatal buccal swabs from all neonates whose cord blood was unable to be obtained (n = 31). We isolated DNA from all samples collected and estimated DNA concentrations and total DNA yield as above. As shown in the Table , we observed significant differences in both measures between umbilical cord blood and buccal swabs in both the partial and total sample isolation groups. The mean DNA yield in the total sample isolation of umbilical cord blood was 116.5 ± 70.8 μg compared with 4.2 ± 4.0 μg in total sample isolation of Oragene buccal swabs ( P < .0001). The partial samples yielded total DNA equal to 14.0 ± 10.3 μg for blood vs 1.1 ± 0.7 μg for buccal swabs ( P < .0001). Comparison of DNA concentrations gave similar results, with a mean DNA concentration from total sample isolation of umbilical cord blood and buccal swabs of 209.0 ± 110.7 ng/μL and 6.9 ± 6.7 ng/μL, respectively ( P < .0001). In the partial sample, isolation DNA concentrations were 70.0 ± 51.4 ng/μL and 11.3 ± 6.7 ng/μL, respectively ( P < .0001).



TABLE

DNA concentrations and yield in entire and partial samples of umbilical cord blood and buccal swabs




























Method of DNA collection Umbilical cord blood (total sample, n = 35) Oragene buccal swabs (total sample, n = 20) Umbilical cord blood (partial sample, n = 30) Oragene buccal swabs (partial sample, n = 11)
Mean DNA concentration, ng/μL (range)


  • 209.0 ± 110.7 a



  • (7.4–468.5)

6.9 ± 6.7 a
(0.6–29.2)



  • 70.0 ± 51.4 a



  • (8.9–204.7)




  • 11.3 ± 6.7 a



  • (4.3–26.2)

Average eluted DNA volume, μL 540 600 200 100
Mean total DNA yield, μg (range)


  • 116.5 ± 70.8 a



  • (2.2–281.1)

4.2 ± 4.0 a
(0.4–17.5)



  • 14.0 ± 10.3 a



  • (1.8–40.9)

1.1 ± 0.7 a
(0.4–2.6)

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 21, 2017 | Posted by in GYNECOLOGY | Comments Off on Collection of human genomic DNA from neonates: a comparison between umbilical cord blood and buccal swabs

Full access? Get Clinical Tree

Get Clinical Tree app for offline access